“Targeting NAD(+) Metabolism for Cancer Therapy: Limiting Proliferation and Alleviating Immunosuppression”

https://pubmed.ncbi.nlm.nih.gov/38116009

The abstract reports that targeting NAD(+) metabolism, by inhibiting its synthesis or degrading enzymes, has dual therapeutic potential in cancer treatment by limiting cancer cell proliferation and alleviating the immunosuppressive tumor microenvironment.